ANP32A and breast carcinoma: Interestingly, ANP32A and STK24 were observed to be significantly up-regulated with PRG treatment in nPR(+) T47D cells (Fig. 8, panel A1), preliminarily classifying these genes as PRG-inducible biomarkers in Luminal-A breast cancer cells.